TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Abingdon Health PLC ( (GB:ABDX) ).
Abingdon Health PLC has announced a retail offer to raise up to £200,000 through the issuance of new ordinary shares at a price of 6 pence per share. This initiative aims to engage retail shareholders in the UK, allowing them to participate alongside institutional investors. The retail offer is part of a broader fundraising effort, which includes a separate placing of shares, although the two are not interdependent. The offer is expected to close on 16 October 2025, with shares commencing trading on 31 October 2025, subject to certain conditions being met.
The most recent analyst rating on (GB:ABDX) stock is a Hold with a £7.00 price target. To see the full list of analyst forecasts on Abingdon Health PLC stock, see the GB:ABDX Stock Forecast page.
Spark’s Take on GB:ABDX Stock
According to Spark, TipRanks’ AI Analyst, GB:ABDX is a Neutral.
Abingdon Health PLC’s overall score is driven by its strong business development activities and promising revenue growth, albeit overshadowed by persistent profitability challenges and valuation concerns. Technical indicators suggest a neutral outlook, while recent corporate events present potential for future growth.
To see Spark’s full report on GB:ABDX stock, click here.
More about Abingdon Health PLC
Abingdon Health PLC is a leading international company specializing in the development, manufacturing, and regulatory services for rapid diagnostic tests and medical technology. The company is focused on providing innovative solutions in the healthcare sector, catering to both retail and institutional investors.
Average Trading Volume: 152,799
Technical Sentiment Signal: Sell
Current Market Cap: £11.71M
Find detailed analytics on ABDX stock on TipRanks’ Stock Analysis page.